Lansoprazole Capsule, Delayed Release
Product Images NDC 71335-9693

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 71335-9693). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lansoprazolefigure1 (Lansoprazolefigure1)

Lansoprazolefigure1 (Lansoprazolefigure1)
A line graph showing mean severity of day heartburn by study day for evaluable patients receiving placebo, Lansoprazole 15 mg once daily, and Lansoprazole 30 mg once daily. The x-axis represents days from start of treatment (up to 60 days), and the y-axis indicates mean severity of day heartburn on a scale from 0 (none) to 3 (severe). Lansoprazole treatments show decreasing heartburn severity over time compared to placebo.*
FDA Label Image

Lansoprazolefigure2 (Lansoprazolefigure2)

Lansoprazolefigure2 (Lansoprazolefigure2)
A line graph showing the mean severity of night heartburn over days from the start of treatment. The graph compares placebo, Lansoprazole 15 mg QD, and Lansoprazole 30 mg QD, displaying severity scores ranging from none to severe over approximately 60 days.*
FDA Label Image

Lansoprazolestructure (Lansoprazolestructure)

Lansoprazolestructure (Lansoprazolestructure)
Chemical structure of lansoprazole, showing its molecular arrangement with labeled atoms including sulfur, nitrogen, fluorine, carbon, and hydrogen in the compound.*
FDA Label Image

Camber (Camber)

FDA Label Image

Label (Lbl713359693)

Label (Lbl713359693)
Label for Lansoprazole Delayed-Release Capsules, USP, 15 mg strength, containing 30 capsules. The label includes storage instructions, dosage form as capsules, NDC 71335-9693-1, and indicates the product is prescription only. It is repackaged by Bryant Ranch Prepack, Inc., Burbank, CA, and manufactured by Cadila Healthcare Limited. The BRP Pharmaceuticals logo is visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.